[1] 张澍,黄从新,黄德嘉.心电生理及心脏起搏专科医师培训教程[M].北京:人民卫生出版社,2007:226-236.[2] 郭继鸿,张萍.临床心脏电生理学技术和理论[M].天津:天津科技翻译出版公司,2005:305-401.[3] 张文博.心电图诊断线索与误区[M].北京:人民军医出版社,2010:283-309.[4] 王福军.心律失常//徐新献,等.内科常见病症现代治疗[M].成都:四川科学技术出版社,2006:187-257.[5] Gollob MH,Roberts R.AMPactivated protein kinase and familial WolffParkinsonWhite syndrome:new perspectives on heart development and arrhythmogenesis[J].Eur Heart J,2002,23(9):679-681.[6] Prystowsky EN.Diagnosis and management of the preexcitation syndromes[J].Curr Probl Cardiol,1988,13(4):225-310.[7] MacRae CA,Ghaisas N,Kass S,et al.Familial Hypertrophic cardiomyopathy with WolffParkinsonWhite syndrome maps to a locus on chromosome 7q3[J].J Clin Invest,1995,96(3):1216-1220.[8] Anderson KP,Vidaillet HJ Jr,Josephson ME.A gene responsible for familial WolffParkinsonWhite syndrome[J].N Engl J Med,2001,345(14):1063-1064.[9] Gollob MH,Green MS,Tang AS,et al.PRKAG2 cardiac syndrome : familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy[J].Curr Opin Cardiol,2002,17(3):229-234.[10] Bromberg BI,Lindsay BD,Cain ME,et al.Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with WolffParkinsonWhite syndrome[J].J Am Coll Cardiol,1996,27(3):690-695.[11] Wellens HJ,Durrer D.Effect of procaine amide, quinidine, and ajmaline in the WolffParkinsonWhite syndrome[J].Circulation,1974,50(1):114-120.[12] Podrid PJ,Anderson JL.Safety and tolerability of longterm propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group[J].Am J Cardiol,1996,78(4):430-434.[13] Antunes E,Brugada J,Steurer G,et al.The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway[J].Pacing Clin Electrophysiol,1994,17(9):1515-1524.[14] Cakmak N,Oguz E,Sayar NA,et al.Effect of radiofrequency catheter ablation on myocardial performance index in patients with WolffParkinsonWhite syndrome[J].Eur J Echocardiogra,2006,7:159.[15] Wellens HJ.Should catheter ablation be performed in asymptomatic patients with WolffParkinsonWhite syndrome? When to perform catheter ablation in asymptomatic patients with a WolffParkinsonWhite electrocardiogram[J].Circulation,2005,112(14):2201-2207.[16] Pappone C,Santinelli V.Should catheter ablation be performed in asymptomatic patients with WolffParkinsonWhite syndrome? Catheter ablation should be performed in asymptomatic patients with WolffParkinsonWhite syndrome[J].Circulation,2005,112(14):2207-2215.[17] Pappone C,Santinelli V,Rosanio S,et al.Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with WolffParkinsonWhite pattern:results from a large prospective longterm followup study[J].J Am Coll Cardiol,2003,41(2):239-244.[18] Pappone C,Vicedomini G,Manguso F,et al.Risk of malignant arrhythmias in initially symptomatic patients with WolffParkinsonWhite syndrome: results of a prospective longterm electrophysiological followup study[J].Circulation,2012,125(5):661-668.[19] Sethi KK,Dhall A,Chadha DS,et al.WPW and preexcitation syndromes[J].J Assoc Physicians India,2007,55 Suppl:10-15.[20] Ho SY.Accessory atrioventricular pathways: getting to the origins[J].Circulation,2008,117(12):1502-1504. |
|
|
|